NasdaqCM - Nasdaq Real Time Price USD

NRx Pharmaceuticals, Inc. (NRXP)

Compare
3.0500
-0.0900
(-2.87%)
As of 1:26:21 PM EST. Market Open.
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
7,315.0000
25,816.0000
32,729.0000
2,941.0000
Total Liabilities Net Minority Interest
19,048.0000
18,407.0000
11,923.0000
46,712.0000
Total Equity Gross Minority Interest
-11,733.0000
7,409.0000
20,806.0000
-43,771.0000
Total Capitalization
-11,733.0000
10,231.0000
20,806.0000
-43,223.0000
Preferred Stock Equity
3.0000
--
--
--
Common Stock Equity
-11,736.0000
7,409.0000
20,806.0000
-43,771.0000
Net Tangible Assets
-11,733.0000
7,409.0000
20,806.0000
-43,771.0000
Working Capital
-12,164.0000
10,210.0000
20,791.0000
-43,234.0000
Invested Capital
-2,575.0000
17,934.0000
21,324.0000
-42,974.0000
Tangible Book Value
-11,736.0000
7,409.0000
20,806.0000
-43,771.0000
Total Debt
9,161.0000
10,525.0000
518.0000
797.0000
Net Debt
4,566.0000
--
--
--
Share Issued
8,391.9550
6,644.2980
5,881.0550
--
Ordinary Shares Number
8,391.9550
6,644.2980
5,881.0550
--
12/31/2020 - 12/4/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers